[Skip to Navigation]
Sign In

Featured Clinical Reviews

JAMA Insights
Women's Health
July 22, 2022

Contraception in Women With Cardiovascular Disease

Author Affiliations
  • 1Cardiovascular Division, Department of Medicine, Washington University in St Louis, St Louis, Missouri
  • 2Department of Obstetrics and Gynecology and Reproductive Biology, University Hospitals Cleveland Medical Center, Cleveland, Ohio
JAMA. 2022;328(6):577-578. doi:10.1001/jama.2022.11541

An increasing population of women of childbearing age have underlying congenital or acquired cardiovascular disease (CVD) in the US.1,2 For instance, among women aged 20 to 29 years, the prevalence of CVD (eg, coronary heart disease, heart failure, stroke, and hypertension) is estimated at 11.5%.3 The reasons for this include improved pediatric cardiac surgical care, which has enabled more than 90% of children with congenital heart disease to survive to adulthood, and increasing rates of cardiovascular (CV) risk factors among young women (eg, obesity, hypertension, and diabetes).2

Add or change institution